Anixa Biosciences (ANIX) News Today $3.27 -0.07 (-2.10%) (As of 12/1/2023 ET) Add Compare Share Share Today's Range$3.25▼$3.4350-Day Range$2.85▼$3.6452-Week Range$2.75▼$6.45Volume45,376 shsAverage Volume39,083 shsMarket Capitalization$101.60 millionP/E RatioN/ADividend YieldN/APrice Target$10.50 HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBuy Rating for Anixa Biosciences Backed by Strong Patent Position and Promising CAR-T Therapy Trial Resultsmarkets.businessinsider.com - November 29 at 7:51 AMAnixa Gains on European Patentbaystreet.ca - November 27 at 10:26 AMAnixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technologyfinance.yahoo.com - November 27 at 9:32 AMArdelyx (ARDX) Up on Xphozah's Orphan Tag for Hyperphosphatemiafinance.yahoo.com - November 17 at 11:40 AMDermata (DRMA) Up on FDA Nod to Begin Pivotal Study of Acne Drugfinance.yahoo.com - November 17 at 11:40 AMMoleculin (MBRX) Up 7% on Upbeat Updates From Annamycin Studiesfinance.yahoo.com - November 14 at 12:50 PMCatalyst (CPRX) Q3 Earnings Miss, Sales Top, '23 View Upfinance.yahoo.com - November 9 at 3:04 PMAnixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conferencefinance.yahoo.com - October 31 at 9:33 AMAnalysts Offer Insights on Healthcare Companies: Anixa Biosciences (ANIX) and Amylyx Pharmaceuticals Inc (AMLX)markets.businessinsider.com - October 16 at 9:54 AMBears are Losing Control Over ANIXA BIOSCIENCES INC (ANIX), Here's Why It's a 'Buy' Nowfinance.yahoo.com - October 13 at 12:54 PMAnixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trialfinance.yahoo.com - October 13 at 10:10 AMAnixa Biosciences Director Acquires 16,000 Shares After Exercising Company Stock Optionsbenzinga.com - October 11 at 12:14 PMAnixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technologyfinance.yahoo.com - October 3 at 1:13 PMANIXA BIOSCIENCES INC (ANIX) Upgraded to Buy: What Does It Mean for the Stock?finance.yahoo.com - September 21 at 3:05 PMAnixa Biosciences Establishes Cancer Business Advisory Boardfinance.yahoo.com - September 19 at 11:11 AMThe 3 Most Undervalued Cheap Stocks to Buy in September 2023finance.yahoo.com - September 19 at 1:23 AMAnixa Biosciences (ANIX) Receives a Buy from H.C. Wainwrightmarkets.businessinsider.com - September 18 at 3:07 PMHere's Why We're Not Too Worried About Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Situationfinance.yahoo.com - September 10 at 4:25 PMAnixa Biosciences (ANIX) Price Target Increased by 14.29% to 12.24msn.com - August 31 at 4:47 PMAnixa Biosciences to Participate in September Investor Conferencesfinance.yahoo.com - August 31 at 9:45 AMAnixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical Trialfinance.yahoo.com - August 28 at 9:00 AMAnixa Biosciences: Early Stage, Low Cash. Does It Matter?msn.com - August 25 at 6:21 PMSmall Biotech Company Hopes its Vaccine Will End Breast Cancermsn.com - August 16 at 8:57 PMBiotech Company Hopes to Eliminate Breast Cancer with a Vaccinemsn.com - August 15 at 6:52 PMAnixa Biosciences Announces Invited Presentation on Ovarian Cancer CAR-T Therapy at the 8th Annual CAR-TCR Summitfinance.yahoo.com - August 14 at 3:20 PMAnixa Biosciences, Inc.: Could Anixa Biosciences Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?finanznachrichten.de - August 10 at 1:59 PMCould Anixa Biosciences (NASDAQ:ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?finance.yahoo.com - August 10 at 1:59 PMCould Anixa Biosciences (NASDAQ: ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer?benzinga.com - August 9 at 11:05 AMAnalysts Offer Insights on Healthcare Companies: Anixa Biosciences (ANIX), Roche Holding AG (OtherRHHVF) and Bristol-Myers Squibb (BMY)markets.businessinsider.com - July 28 at 2:17 PMAnixa Biosciences' (ANIX) "Buy" Rating Reaffirmed at HC Wainwrightmarketbeat.com - July 28 at 11:52 AMAnixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technologyfinance.yahoo.com - July 27 at 11:46 AMOhio woman part of groundbreaking breast cancer vaccine trialmsn.com - July 25 at 10:18 AMNE Ohio woman part of groundbreaking breast cancer vaccine trialmsn.com - July 24 at 6:50 PMGilead (GILD) Ends Myelodysplastic Syndromes Study on Magrolimabfinance.yahoo.com - July 24 at 1:26 PMAnixa Biosciences And 2 Other Penny Stocks Insiders Are Aggressively Buyingbenzinga.com - July 24 at 8:26 AMVir Biotechnology (VIR) Down on Influenza Study Failurefinance.yahoo.com - July 21 at 2:49 PMInsider Buying: Anixa Biosciences, Inc. (NASDAQ:ANIX) CFO Buys 5,500 Shares of Stockmarketbeat.com - July 21 at 11:07 AMH.C. Wainwright Sticks to Its Buy Rating for Anixa Biosciences (ANIX)markets.businessinsider.com - July 12 at 10:24 AMAnixa Biosciences Announces Issuance of Canadian Patent for its CAR-T Cancer Therapy Technologyfinance.yahoo.com - July 11 at 1:03 PMASLAN (ASLN) Down 25% on Mixed Results From Skin Disease Studyfinance.yahoo.com - July 7 at 1:02 PMWhat Makes ANIXA BIOSCIENCES INC (ANIX) a New Buy Stockfinance.yahoo.com - June 22 at 3:50 PMAnixa Biosciences Stock (NASDAQ:ANIX), Dividendsbenzinga.com - June 20 at 11:45 PM6 Analysts Have This to Say About Anixa Biosciencesmarkets.businessinsider.com - June 19 at 5:36 PMHC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Targetbenzinga.com - June 19 at 7:36 AMUS3528H109.MU - ANIXA BIOSCIENCES DL -,01finance.yahoo.com - June 17 at 10:20 AMThe Latest Analyst Ratings for Anixa Biosciencesmarkets.businessinsider.com - May 23 at 1:23 PMH.C. Wainwright Reaffirms Their Buy Rating on Anixa Biosciences (ANIX)markets.businessinsider.com - May 23 at 8:23 AMAnixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical Trialfinance.yahoo.com - May 22 at 9:45 AMIs Anixa Biosciences (ANIX) Outperforming Other Medical Stocks This Year?finance.yahoo.com - April 25 at 1:38 PMChardan Capital Reiterates Anixa Biosciences (ANIX) Buy Recommendationmsn.com - April 19 at 3:27 AM Get Anixa Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter. Email Address ANIX Media Mentions By Week ANIX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANIX News Sentiment▼0.180.76▲Average Medical News Sentiment ANIX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANIX Articles This Week▼41▲ANIX Articles Average Week Get Anixa Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cue Biopharma News Emergent BioSolutions News BioLineRx News Organigram News Immix Biopharma News Kinnate Biopharma News Eagle Pharmaceuticals News Vistagen Therapeutics News Rani Therapeutics News DiaMedica Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:ANIX) was last updated on 12/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anixa Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.